Among peptide stacks studied in the research community, CJC-1295 and Ipamorelin stands out as one of the most data-backed approaches to growth hormone axis modulation. Both compounds work through complementary mechanisms that together produce more sustained and physiologically appropriate GH release than either alone.
What Is CJC-1295?
CJC-1295 is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH) engineered for extended stability. Native GHRH has a half-life of just minutes; CJC-1295 is designed to last longer. Two variants exist: CJC-1295 without DAC (Mod GRF 1-29, ~30 min half-life, more physiological pulsatility) and CJC-1295 with DAC (~6–8 day half-life via albumin binding, sustained GH/IGF-1 elevation). Published Phase I/II trials showed 2–10 fold GH increases over baseline and 1.5–3 fold IGF-1 elevation sustained over 28 days, plus increased lean body mass.
What Is Ipamorelin?
Ipamorelin is a selective Growth Hormone Secretagogue and ghrelin receptor agonist — a pentapeptide that stimulates GH release through GHSR receptors, distinct from GHRH receptors. Its standout feature is exceptional selectivity: it stimulates GH without meaningfully affecting cortisol, ACTH, or prolactin — distinguishing it from older GHRPs like GHRP-2 and GHRP-6.
Why Combine Them?
GH release is regulated by two distinct pathways: the GHRH pathway (stimulated by CJC-1295) and the ghrelin/GHSR pathway (stimulated by ipamorelin). When both are activated simultaneously, research demonstrates synergistic GH release significantly greater than either compound alone — mirroring the body’s natural pulsatile GH coordination.
CJC-1295 Variant Comparison
| Consideration | Without DAC | With DAC |
|---|---|---|
| Half-life | ~30 minutes | ~6–8 days |
| GH pulse pattern | Mimics natural pulsatile release | More sustained, blunted pulse |
| Research preference for stacking | More physiological pulsatility | Longer duration coverage |
Conclusion
The CJC-1295 + Ipamorelin stack represents one of the most well-supported combinations in growth hormone secretagogue research. Their complementary receptor targets, clean safety profiles, and demonstrated human biomarker efficacy make this one of the most frequently studied peptide stacks in the literature. Combat Research carries both CJC-1295 variants and Ipamorelin verified to pharmaceutical-grade purity.
For research purposes only. Not for human therapeutic use.
Related Research Articles
- Ipamorelin: Complete Research Guide
- Sermorelin: The Original GH Peptide
- MK-677 (Ibutamoren) Research Guide
Shop CJC-1295 + Ipamorelin at Combat Research
Research-grade CJC-1295 No DAC and Ipamorelin, individually or as a pre-blended stack. ≥99% purity, third-party verified.
